Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)

BackgroundObservational studies have suggested that a high respiratory exchange ratio (RER) is associated with the occurrence of postoperative complications. The study’s primary objective is to demonstrate that the incidence of postoperative complications is lower in an interventional group (patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current controlled trials in cardiovascular medicine 2020-11, Vol.21 (1), p.958-958, Article 958
Hauptverfasser: Bar, Stéphane, Boivin, Pierre, El Amine, Younes, Descamps, Richard, Moussa, Mouhamed, Abou Arab, Osama, Fischer, Marc-Olivier, Dupont, Hervé, Lorne, Emmanuel, Guinot, Pierre-Grégoire
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 958
container_issue 1
container_start_page 958
container_title Current controlled trials in cardiovascular medicine
container_volume 21
creator Bar, Stéphane
Boivin, Pierre
El Amine, Younes
Descamps, Richard
Moussa, Mouhamed
Abou Arab, Osama
Fischer, Marc-Olivier
Dupont, Hervé
Lorne, Emmanuel
Guinot, Pierre-Grégoire
description BackgroundObservational studies have suggested that a high respiratory exchange ratio (RER) is associated with the occurrence of postoperative complications. The study’s primary objective is to demonstrate that the incidence of postoperative complications is lower in an interventional group (patients monitored using a hemodynamic algorithm that incorporates the RER) than in a control group (treated according to standard practice).MethodsWe shall perform a prospective, multicenter, randomized, open-label, superiority trial of consecutive patients undergoing major noncardiac surgery (i.e., abdominal, vascular, and orthopedic surgery). The control group will be treated according to the current guidelines on standard hemodynamic care. The interventional group will be treated according to an algorithm based on the RER. The primary outcome will be the occurrence of at least one complication in the 7 days following surgery. The secondary outcomes will be the length of hospital stay, the total number of complications per patient, the 30-day mortality, the total intraoperative volume of fluids administered, and the Sequential [sepsis-related] Organ Failure Assessment (SOFA) score and laboratory data measured on postoperative days 1, 2, and 7. A total of 350 patients will be included.DiscussionIn the operating theater, the RER is potentially a continuously available, easy-to-read, indirect marker of tissue hypoperfusion and postoperative complications. If the RER does predict the occurrence of tissue hypoperfusion, it will help the physician to provide personalized hemodynamic management and limit the side effects associated with excessive hemodynamic optimization (volume overload, vasoconstriction, etc.).Trial registrationClinicalTrials.gov NCT03852147. Registered on February 25, 2019
doi_str_mv 10.1186/s13063-020-04879-x
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7682128</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2812313335</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-e54a6bc103d5e5d0107a9a046caf720273abaacfb23f056edf43862fb57e244f3</originalsourceid><addsrcrecordid>eNpdUktv1DAQjhCIlsIf4GSJS3sI-JXHckCqqsKutFJBomdrYjsbr-J4sZ3Vpn-Ov4bTVAh68mi-x8xYX5a9J_gjIXX5KRCGS5ZjinPM62qVn15k56TiRV5SUrz8pz7L3oSwx5izFeOvszPGKK2rip1nvzeDMkejRujNg1ao09apaQBrJHKHaKx5gGjcgHajUQlvJmSSwmsZkdUQRq-tHiJyLYqdRl6Hg_EQnZ-QPskOhl1qzg5JhizsnUdJs9N--oxCHNWEDt5FJ12P2oRBIg_K2cddpBuid32fyugN9OhyHnH3fb35cX-7qK_eZq9a6IN-9_ReZPdfb3_erPPt3bfNzfU2l5yTmOuCQ9lIgpkqdKEwwRWsAPNSQltRTCsGDYBsG8paXJRatZzVJW2botKU85ZdZF8W38PYWK1kutlDLw7eWPCTcGDE_8hgOrFzR1GVNSW0TgZXi0H3TLa-3oq5h1lRlZzUR5K4l0_DvPs16hCFNUHqvodBuzEIyhOR13U52354Rt270Q_pKwStCWWEMVYkFl1Y0rsQvG7_bkCwmLMkliyJlCXxmCVxYn8ABB3Aww</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2812313335</pqid></control><display><type>article</type><title>Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><source>Springer Nature - Complete Springer Journals</source><source>PubMed Central</source><creator>Bar, Stéphane ; Boivin, Pierre ; El Amine, Younes ; Descamps, Richard ; Moussa, Mouhamed ; Abou Arab, Osama ; Fischer, Marc-Olivier ; Dupont, Hervé ; Lorne, Emmanuel ; Guinot, Pierre-Grégoire</creator><creatorcontrib>Bar, Stéphane ; Boivin, Pierre ; El Amine, Younes ; Descamps, Richard ; Moussa, Mouhamed ; Abou Arab, Osama ; Fischer, Marc-Olivier ; Dupont, Hervé ; Lorne, Emmanuel ; Guinot, Pierre-Grégoire</creatorcontrib><description>BackgroundObservational studies have suggested that a high respiratory exchange ratio (RER) is associated with the occurrence of postoperative complications. The study’s primary objective is to demonstrate that the incidence of postoperative complications is lower in an interventional group (patients monitored using a hemodynamic algorithm that incorporates the RER) than in a control group (treated according to standard practice).MethodsWe shall perform a prospective, multicenter, randomized, open-label, superiority trial of consecutive patients undergoing major noncardiac surgery (i.e., abdominal, vascular, and orthopedic surgery). The control group will be treated according to the current guidelines on standard hemodynamic care. The interventional group will be treated according to an algorithm based on the RER. The primary outcome will be the occurrence of at least one complication in the 7 days following surgery. The secondary outcomes will be the length of hospital stay, the total number of complications per patient, the 30-day mortality, the total intraoperative volume of fluids administered, and the Sequential [sepsis-related] Organ Failure Assessment (SOFA) score and laboratory data measured on postoperative days 1, 2, and 7. A total of 350 patients will be included.DiscussionIn the operating theater, the RER is potentially a continuously available, easy-to-read, indirect marker of tissue hypoperfusion and postoperative complications. If the RER does predict the occurrence of tissue hypoperfusion, it will help the physician to provide personalized hemodynamic management and limit the side effects associated with excessive hemodynamic optimization (volume overload, vasoconstriction, etc.).Trial registrationClinicalTrials.gov NCT03852147. Registered on February 25, 2019</description><identifier>ISSN: 1745-6215</identifier><identifier>EISSN: 1745-6215</identifier><identifier>DOI: 10.1186/s13063-020-04879-x</identifier><identifier>PMID: 33228773</identifier><language>eng</language><publisher>London: BioMed Central</publisher><subject>Anaerobic threshold ; Anesthesiology ; Blood pressure ; Clinical trials ; Consent ; Critical care ; Hemodynamics ; Life Sciences ; Metabolism ; Mortality ; Optimization ; Patients ; Study Protocol ; Vascular surgery</subject><ispartof>Current controlled trials in cardiovascular medicine, 2020-11, Vol.21 (1), p.958-958, Article 958</ispartof><rights>The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-e54a6bc103d5e5d0107a9a046caf720273abaacfb23f056edf43862fb57e244f3</citedby><cites>FETCH-LOGICAL-c441t-e54a6bc103d5e5d0107a9a046caf720273abaacfb23f056edf43862fb57e244f3</cites><orcidid>0000-0002-4630-5833 ; 0000-0002-5644-3412 ; 0000-0002-7019-9727 ; 0000-0003-3766-716X ; 0000-0001-6409-5449 ; 0000-0002-8887-2377</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682128/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682128/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://u-picardie.hal.science/hal-03576418$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Bar, Stéphane</creatorcontrib><creatorcontrib>Boivin, Pierre</creatorcontrib><creatorcontrib>El Amine, Younes</creatorcontrib><creatorcontrib>Descamps, Richard</creatorcontrib><creatorcontrib>Moussa, Mouhamed</creatorcontrib><creatorcontrib>Abou Arab, Osama</creatorcontrib><creatorcontrib>Fischer, Marc-Olivier</creatorcontrib><creatorcontrib>Dupont, Hervé</creatorcontrib><creatorcontrib>Lorne, Emmanuel</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><title>Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)</title><title>Current controlled trials in cardiovascular medicine</title><description>BackgroundObservational studies have suggested that a high respiratory exchange ratio (RER) is associated with the occurrence of postoperative complications. The study’s primary objective is to demonstrate that the incidence of postoperative complications is lower in an interventional group (patients monitored using a hemodynamic algorithm that incorporates the RER) than in a control group (treated according to standard practice).MethodsWe shall perform a prospective, multicenter, randomized, open-label, superiority trial of consecutive patients undergoing major noncardiac surgery (i.e., abdominal, vascular, and orthopedic surgery). The control group will be treated according to the current guidelines on standard hemodynamic care. The interventional group will be treated according to an algorithm based on the RER. The primary outcome will be the occurrence of at least one complication in the 7 days following surgery. The secondary outcomes will be the length of hospital stay, the total number of complications per patient, the 30-day mortality, the total intraoperative volume of fluids administered, and the Sequential [sepsis-related] Organ Failure Assessment (SOFA) score and laboratory data measured on postoperative days 1, 2, and 7. A total of 350 patients will be included.DiscussionIn the operating theater, the RER is potentially a continuously available, easy-to-read, indirect marker of tissue hypoperfusion and postoperative complications. If the RER does predict the occurrence of tissue hypoperfusion, it will help the physician to provide personalized hemodynamic management and limit the side effects associated with excessive hemodynamic optimization (volume overload, vasoconstriction, etc.).Trial registrationClinicalTrials.gov NCT03852147. Registered on February 25, 2019</description><subject>Anaerobic threshold</subject><subject>Anesthesiology</subject><subject>Blood pressure</subject><subject>Clinical trials</subject><subject>Consent</subject><subject>Critical care</subject><subject>Hemodynamics</subject><subject>Life Sciences</subject><subject>Metabolism</subject><subject>Mortality</subject><subject>Optimization</subject><subject>Patients</subject><subject>Study Protocol</subject><subject>Vascular surgery</subject><issn>1745-6215</issn><issn>1745-6215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdUktv1DAQjhCIlsIf4GSJS3sI-JXHckCqqsKutFJBomdrYjsbr-J4sZ3Vpn-Ov4bTVAh68mi-x8xYX5a9J_gjIXX5KRCGS5ZjinPM62qVn15k56TiRV5SUrz8pz7L3oSwx5izFeOvszPGKK2rip1nvzeDMkejRujNg1ao09apaQBrJHKHaKx5gGjcgHajUQlvJmSSwmsZkdUQRq-tHiJyLYqdRl6Hg_EQnZ-QPskOhl1qzg5JhizsnUdJs9N--oxCHNWEDt5FJ12P2oRBIg_K2cddpBuid32fyugN9OhyHnH3fb35cX-7qK_eZq9a6IN-9_ReZPdfb3_erPPt3bfNzfU2l5yTmOuCQ9lIgpkqdKEwwRWsAPNSQltRTCsGDYBsG8paXJRatZzVJW2botKU85ZdZF8W38PYWK1kutlDLw7eWPCTcGDE_8hgOrFzR1GVNSW0TgZXi0H3TLa-3oq5h1lRlZzUR5K4l0_DvPs16hCFNUHqvodBuzEIyhOR13U52354Rt270Q_pKwStCWWEMVYkFl1Y0rsQvG7_bkCwmLMkliyJlCXxmCVxYn8ABB3Aww</recordid><startdate>20201123</startdate><enddate>20201123</enddate><creator>Bar, Stéphane</creator><creator>Boivin, Pierre</creator><creator>El Amine, Younes</creator><creator>Descamps, Richard</creator><creator>Moussa, Mouhamed</creator><creator>Abou Arab, Osama</creator><creator>Fischer, Marc-Olivier</creator><creator>Dupont, Hervé</creator><creator>Lorne, Emmanuel</creator><creator>Guinot, Pierre-Grégoire</creator><general>BioMed Central</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-4630-5833</orcidid><orcidid>https://orcid.org/0000-0002-5644-3412</orcidid><orcidid>https://orcid.org/0000-0002-7019-9727</orcidid><orcidid>https://orcid.org/0000-0003-3766-716X</orcidid><orcidid>https://orcid.org/0000-0001-6409-5449</orcidid><orcidid>https://orcid.org/0000-0002-8887-2377</orcidid></search><sort><creationdate>20201123</creationdate><title>Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)</title><author>Bar, Stéphane ; Boivin, Pierre ; El Amine, Younes ; Descamps, Richard ; Moussa, Mouhamed ; Abou Arab, Osama ; Fischer, Marc-Olivier ; Dupont, Hervé ; Lorne, Emmanuel ; Guinot, Pierre-Grégoire</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-e54a6bc103d5e5d0107a9a046caf720273abaacfb23f056edf43862fb57e244f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Anaerobic threshold</topic><topic>Anesthesiology</topic><topic>Blood pressure</topic><topic>Clinical trials</topic><topic>Consent</topic><topic>Critical care</topic><topic>Hemodynamics</topic><topic>Life Sciences</topic><topic>Metabolism</topic><topic>Mortality</topic><topic>Optimization</topic><topic>Patients</topic><topic>Study Protocol</topic><topic>Vascular surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bar, Stéphane</creatorcontrib><creatorcontrib>Boivin, Pierre</creatorcontrib><creatorcontrib>El Amine, Younes</creatorcontrib><creatorcontrib>Descamps, Richard</creatorcontrib><creatorcontrib>Moussa, Mouhamed</creatorcontrib><creatorcontrib>Abou Arab, Osama</creatorcontrib><creatorcontrib>Fischer, Marc-Olivier</creatorcontrib><creatorcontrib>Dupont, Hervé</creatorcontrib><creatorcontrib>Lorne, Emmanuel</creatorcontrib><creatorcontrib>Guinot, Pierre-Grégoire</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current controlled trials in cardiovascular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bar, Stéphane</au><au>Boivin, Pierre</au><au>El Amine, Younes</au><au>Descamps, Richard</au><au>Moussa, Mouhamed</au><au>Abou Arab, Osama</au><au>Fischer, Marc-Olivier</au><au>Dupont, Hervé</au><au>Lorne, Emmanuel</au><au>Guinot, Pierre-Grégoire</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)</atitle><jtitle>Current controlled trials in cardiovascular medicine</jtitle><date>2020-11-23</date><risdate>2020</risdate><volume>21</volume><issue>1</issue><spage>958</spage><epage>958</epage><pages>958-958</pages><artnum>958</artnum><issn>1745-6215</issn><eissn>1745-6215</eissn><abstract>BackgroundObservational studies have suggested that a high respiratory exchange ratio (RER) is associated with the occurrence of postoperative complications. The study’s primary objective is to demonstrate that the incidence of postoperative complications is lower in an interventional group (patients monitored using a hemodynamic algorithm that incorporates the RER) than in a control group (treated according to standard practice).MethodsWe shall perform a prospective, multicenter, randomized, open-label, superiority trial of consecutive patients undergoing major noncardiac surgery (i.e., abdominal, vascular, and orthopedic surgery). The control group will be treated according to the current guidelines on standard hemodynamic care. The interventional group will be treated according to an algorithm based on the RER. The primary outcome will be the occurrence of at least one complication in the 7 days following surgery. The secondary outcomes will be the length of hospital stay, the total number of complications per patient, the 30-day mortality, the total intraoperative volume of fluids administered, and the Sequential [sepsis-related] Organ Failure Assessment (SOFA) score and laboratory data measured on postoperative days 1, 2, and 7. A total of 350 patients will be included.DiscussionIn the operating theater, the RER is potentially a continuously available, easy-to-read, indirect marker of tissue hypoperfusion and postoperative complications. If the RER does predict the occurrence of tissue hypoperfusion, it will help the physician to provide personalized hemodynamic management and limit the side effects associated with excessive hemodynamic optimization (volume overload, vasoconstriction, etc.).Trial registrationClinicalTrials.gov NCT03852147. Registered on February 25, 2019</abstract><cop>London</cop><pub>BioMed Central</pub><pmid>33228773</pmid><doi>10.1186/s13063-020-04879-x</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-4630-5833</orcidid><orcidid>https://orcid.org/0000-0002-5644-3412</orcidid><orcidid>https://orcid.org/0000-0002-7019-9727</orcidid><orcidid>https://orcid.org/0000-0003-3766-716X</orcidid><orcidid>https://orcid.org/0000-0001-6409-5449</orcidid><orcidid>https://orcid.org/0000-0002-8887-2377</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1745-6215
ispartof Current controlled trials in cardiovascular medicine, 2020-11, Vol.21 (1), p.958-958, Article 958
issn 1745-6215
1745-6215
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7682128
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; Springer Nature OA Free Journals; Springer Nature - Complete Springer Journals; PubMed Central
subjects Anaerobic threshold
Anesthesiology
Blood pressure
Clinical trials
Consent
Critical care
Hemodynamics
Life Sciences
Metabolism
Mortality
Optimization
Patients
Study Protocol
Vascular surgery
title Individualized hemodynamic optimization guided by indirect measurement of the respiratory exchange ratio in major surgery: study protocol for a randomized controlled trial (the OPHIQUE study)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T12%3A30%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Individualized%20hemodynamic%20optimization%20guided%20by%20indirect%20measurement%20of%20the%20respiratory%20exchange%20ratio%20in%20major%20surgery:%20study%20protocol%20for%20a%20randomized%20controlled%20trial%20(the%20OPHIQUE%20study)&rft.jtitle=Current%20controlled%20trials%20in%20cardiovascular%20medicine&rft.au=Bar,%20St%C3%A9phane&rft.date=2020-11-23&rft.volume=21&rft.issue=1&rft.spage=958&rft.epage=958&rft.pages=958-958&rft.artnum=958&rft.issn=1745-6215&rft.eissn=1745-6215&rft_id=info:doi/10.1186/s13063-020-04879-x&rft_dat=%3Cproquest_pubme%3E2812313335%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2812313335&rft_id=info:pmid/33228773&rfr_iscdi=true